[Federal Register: March 28, 2008 (Volume 73, Number 61)]
[Notices]
[Page 16717-16718]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr28mr08-118]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Application
Pursuant to Title 21 Code of Federal Regulations 1301.34(a), this
is notice that on November 29, 2007, Mallinckrodt Inc., 3600 North
Second Street, St. Louis, Missouri 63147, made application by renewal
to the Drug Enforcement Administration (DEA) for registration as an
importer of the basic classes of controlled substances listed in
schedule II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Phenylacetone (8501)....................... II
Coca Leaves (9040)......................... II
Opium, raw (9600).......................... II
Poppy Straw (9650)......................... II
Poppy Straw Concentrate (9670)............. II
------------------------------------------------------------------------
The company plans to import the listed controlled substances for
the manufacture of controlled substances in bulk for distribution to
its customers.
No comments, objections, or requests for any hearings will be
accepted on any application for registration or re-registration to
import crude opium, poppy straw, concentrate of poppy straw or coca
leaves. As explained in the Correction to Notice of Application
pertaining to Rhodes Technologies, 72 FR 3417 (2007), comments and
requests for hearings on applications to import narcotic raw material
are not appropriate.
Any bulk manufacturer who is presently, or is applying to be,
registered with DEA to manufacture such basic classes of controlled
substances listed in schedule I or II, which fall under the authority
of section 1002(a)(2)(B) of the Act (21 U.S.C. 952(a)(2)(B)) may, in
the circumstances set forth in 21 U.S.C. 958(i), file comments or
objections to the issuance of the proposed registration and may, at the
same time, file a written request for a hearing on such application
pursuant to 21 CFR 1301.43 and in such form as prescribed by 21 CFR
1316.47.
Any such comments or objections being sent via regular mail should
be addressed, in quintuplicate, to the Drug
[[Page 16718]]
Enforcement Administration, Office of Diversion Control, Federal
Register Representative (ODL), Washington, DC 20537, or any being sent
via express mail should be sent to Drug Enforcement Administration,
Office of Diversion Control, Federal Register Representative (ODL),
8701 Morrissette Drive, Springfield, VA 22152; and must be filed no
later than April 28, 2008.
This procedure is to be conducted simultaneously with and
independent of the procedures described in 21 CFR 1301.34(b), (c), (d),
(e) and (f). As noted in a previous notice published in the Federal
Register on September 23, 1975, (40 FR 43745), all applicants for
registration to import a basic class of any controlled substances in
schedule I or II are and will continue to be required to demonstrate to
the Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration, that the requirements for such registration
pursuant to 21 U.S.C. 958(a); 21 U.S.C. 823(a); and 21 CFR 1301.34(b),
(c), (d), (e) and (f) are satisfied.
Dated: March 19, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E8-6375 Filed 3-27-08; 8:45 am]
BILLING CODE 4410-09-P